Legend Biotech Corporation
LEGN
Classifica tra le azioni
#4447
Legend Biotech Corporation, through its subsidiaries, operates as a... Legend Biotech Corporation, through its subsidiaries, operates as a biopharmaceutical company that discovers, develops, manufactures, and commercializes novel cell therapies for oncology and other indications in the United States, China, and Europe. Its lead product candidate is ciltacabtagene autoleucel, or cilta-cel, which is a chimeric antigen receptor (CAR-T) therapy for the treatment of multiple myeloma (MM). The company also has a portfolio of earlier-stage autologous CAR-T product candidates targeting various cancers, including acute lymphoblastic leukemia, gastric cancer, esophageal cancer, pancreatic cancer, colorectal cancer, small cell lung cancer, and non-small cell lung cancer. In addition, it develops allogeneic gamma delta CAR-T and allogeneic CAR-NK product candidates targeting B-cell maturation antigen (BCMA) for MM, which are in investigator-initiated Phase 1 clinical trials in China. The company has a collaboration and license agreement with Janssen Biotech, Inc. for the development and commercialization of cilta-cel, as well as a license agreement with Novartis Pharma AG for the development, manufacture, and commercialization of CAR-T cell therapies targeting delta-like ligand protein 3. Legend Biotech Corporation was founded in 2014 and is headquartered in Somerset, New Jersey.
Prezzo delle azioni
$18.63
Ultima sincronizzazione: 2026-10-21
Capitalizzazione di mercato
$3.45B
Variazione (1 giorno)
-2.00%
Variazione (1 anno)
-41.98%
Paese
US
Scambia Legend Biotech Corporation (LEGN)
Categoria
Healthcare
Storico del prezzo dell'azione per Legend Biotech Corporation (LEGN)
Prezzo di chiusura più alto: $18.74 il 2026-10-01
Prezzo di chiusura più basso: $39.07 il 2020-06-01
Prezzo di chiusura più basso: $39.07 il 2020-06-01
Storico del prezzo dell'azione di Legend Biotech Corporation dal 2020 al 2026
Andamento annuale del prezzo dell'azione
| Anno | Performance |
|---|---|
| 2026 (TTM) | -1.63% |
| 2025 | -35.12% |
| 2024 | -39.91% |
| 2023 | 18.74% |
| 2022 | 6.61% |
| 2021 | 59.18% |
| 2020 | 0.00% |
Prezzo dell'azione per aziende simili o concorrenti
| Azienda | Prezzo dell'azione | Variazione 1a% | Il paese |
|---|---|---|---|
| $527.18 | 23.62% |
US
|
|
| $251.29 | 835.90% |
US
|
|
| $137.83 | -3.78% |
AU
|
|
| $890.85 | 9.42% |
NL
|
|
| $752.87 | 7.01% |
CH
|
